These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22190207)
1. Contrast-induced nephropathy is not preventable. Chambers CE Catheter Cardiovasc Interv; 2012 Jan; 79(1):76-7. PubMed ID: 22190207 [No Abstract] [Full Text] [Related]
2. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention. Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069 [TBL] [Abstract][Full Text] [Related]
3. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G; Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064 [TBL] [Abstract][Full Text] [Related]
4. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929 [TBL] [Abstract][Full Text] [Related]
5. The modern axis of peri-procedural evil. Hillegass WB Catheter Cardiovasc Interv; 2009 Jul; 74(1):56-7. PubMed ID: 19530189 [No Abstract] [Full Text] [Related]
7. The influence of contrast media on kidney function in patients with stable coronary artery disease. Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300 [TBL] [Abstract][Full Text] [Related]
8. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function. Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579 [TBL] [Abstract][Full Text] [Related]
9. Contrast-Induced Nephropathy: A Fact or Fiction in Lower Limb Revascularization? Martínez-Rico C; Martí-Mestre X; Romera-Villegas A; Espinar-Garcia E; Iborra-Ortega E; Vila-Coll R Ann Vasc Surg; 2017 Oct; 44():277-281. PubMed ID: 28479456 [TBL] [Abstract][Full Text] [Related]
10. Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty. Ricottini E; Giannone S; Melfi R; Nusca A; Mangiacapra F; Gallo P; Cocco N; Rinaldi R; Ussia GP; Grigioni F Coron Artery Dis; 2023 Aug; 34(5):372-373. PubMed ID: 37335222 [No Abstract] [Full Text] [Related]
11. Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease". Anselmino M; Biondi-Zoccai G; Sheiban I Circulation; 2008 Feb; 117(7):e166; author reply e167. PubMed ID: 18285573 [No Abstract] [Full Text] [Related]
15. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial. Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740 [TBL] [Abstract][Full Text] [Related]
16. Postprocedural drop in hematocrit versus contrast-induced nephropathy: eggs or chickens? Lai MY; Lin CC; Yang WC Kidney Int; 2005 Sep; 68(3):1371-2; author reply 1372. PubMed ID: 16105079 [No Abstract] [Full Text] [Related]
17. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW; JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187 [TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine and contrast-induced nephropathy. Ritz E N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738 [No Abstract] [Full Text] [Related]
19. [Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics]. Ar'ev AL; Chesnokov AA Adv Gerontol; 2013; 26(3):511-7. PubMed ID: 24640703 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]